ISU Abxis Co., Ltd.
Develops antibody-based immunotherapies for oncology and rare diseases.
086890 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086890001
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로712번길 22, 씨동 5층 (삼평동, 글로벌알앤디센터), 성남시
- Sector:
- Manufacturing
Description
ISU Abxis is a biopharmaceutical company specializing in the research and development of innovative biomedicines, primarily engineered antibody-based immunotherapies. Founded in 2001, the company leverages genetic recombination technology to create novel treatments. Its pipeline is focused on addressing significant unmet medical needs in oncology and rare diseases. Key development programs include therapeutics for cancers like Head and Neck Squamous Cell Carcinoma (ISU104) and treatments for rare genetic disorders such as Fabry disease (Fabagal). The company is dedicated to developing advanced antibody-based therapeutics to improve the quality of life for patients with difficult-to-treat conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-04 00:00 |
주주총회소집결의
|
Korean | 14.7 KB | ||
| 2021-03-04 00:00 |
주주총회소집공고
|
Korean | 167.8 KB | ||
| 2021-03-04 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.1 KB | ||
| 2021-02-16 00:00 |
전환청구권행사
|
Korean | 9.2 KB | ||
| 2020-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | 823.4 KB | ||
| 2020-10-05 00:00 |
투자판단관련주요경영사항(콜롬비아 식약처 애브서틴주 200,400단위 품목허가)
|
Korean | 9.1 KB | ||
| 2020-09-22 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 61.3 KB | ||
| 2020-09-22 00:00 |
[기재정정]주식등의대량보유상황보고서(약식)
|
Korean | 66.4 KB | ||
| 2020-09-17 00:00 |
기업설명회(IR)개최
|
Korean | 8.1 KB | ||
| 2020-09-01 00:00 |
투자판단관련주요경영사항(ISU 104 제 2상 임상시험승인 신청 (US FDA IND Application))
|
Korean | 12.8 KB | ||
| 2020-08-21 00:00 |
전환청구권행사(제 6회차 CB)
|
Korean | 9.3 KB | ||
| 2020-08-21 00:00 |
[기재정정]전환청구권행사(제6회차 CB)
|
Korean | 12.7 KB | ||
| 2020-08-19 00:00 |
투자판단관련주요경영사항(솔리리스 바이오시밀러 ISU305의 임상1상 시험결과)
|
Korean | 18.1 KB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 808.0 KB |
Automate Your Workflow. Get a real-time feed of all ISU Abxis Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ISU Abxis Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ISU Abxis Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
